Chemokine (C-X-C Motif) Ligand 13 (CXCL13) ELISA Kits

Mouse (Murine) Chemokine (C-X-C Motif) Ligand 13 (CXCL13) interaction partners

1. CXCL13, upregulated by peripheral inflammation, acts on CXCR5 on dorsal root ganglia neurons and activates p38, which increases Nav1.8 current density and further contributes to the maintenance of inflammatory pain.

2. CXCL13 acts on CXCR5 (show CXCR5 ELISA Kits) to increase p38 (show CRK ELISA Kits) activation and further contributes to the pathogenesis of orofacial neuropathic pain

3. This study indicated that CXCL13 may be pathogenically involved in Clostridium difficile infection (CDI) and served as a potential new biomarker for diagnosis and prognosis in CDI.

4. CXCL13 has a role in directing B-lymphocyte (show AKAP17A ELISA Kits) migration

5. CXCL13 and CXCR5 (show CXCR5 ELISA Kits) contribute to orofacial pain via ERK (show EPHB2 ELISA Kits)-mediated proinflammatory cytokines production.

6. High glucose could inhibit osteogenic differentiation of mesenchymal stem cells by lncRNA AK028326 mediated down-regulation of CXCL13 expression.

7. Data demonstrate that CXCL13 is not essential in mounting effective peripheral humoral responses, but specifically promotes CNS accumulation of differentiated B cells.

8. overexpression of CXCL13 is associated with myasthenia gravis.

9. Deficiency in Cxcl13 or its receptor, Cxcr5 (show CXCR5 ELISA Kits), significantly attenuated benzo(a)pyrene-induced lung cancer in mice, demonstrating CXCL13's critical role in polycyclic aromatic hydrocarbon-induced lung carcinogenesis.

10. Blockade of CXCL13 significantly reduced urine protein, serum creatinine, and dramatically attenuated renal pathology injury in lupus nephritis in mice.

Human Chemokine (C-X-C Motif) Ligand 13 (CXCL13) interaction partners

1. IL-17 (show IL17A ELISA Kits) enhances the migration of B cells during asthma by inducing CXCL13 chemokine (show CCL1 ELISA Kits) production in structural lung cells.

2. the findings of the present study indicated that the noninvasive investigation of urinary CXCL13/Cr may be valuable for the detection of AR, particularly antibodymediated rejection . In addition, high urinary CXCL13/Cr levels predicted a poor response to steroid treatment and compromised graft function

3. CXCL13 seems to be a useful marker of disease activity in systemic lupus erythematosus, but not in cutaneous lupus erythematosus or chronic cutaneous lupus erythematosus.

4. Serum level of CXCL13 is associated with disease activity in systemic lupus erythematosus but does not seem to be a biomarker for arthritis.

5. Serum CXCL13 positivity was found to be associated with oral symptoms, ocular signs and hyperglobulinemia in Asian Indian patients with primary Sjogren's syndrome.

6. we found that CXCL13 indeed has a high sensitivity and specificity for diagnosing LNB, which means that it can be used as a new diagnostic biomarker for the diagnosis of LNB.

7. the elevated concentrations of CXCL13, CXCL8 (show IL8 ELISA Kits), and CXCL10 (show CXCL10 ELISA Kits) or their increasing CSF (show CSF2 ELISA Kits)/serum ratios may be potential biomarkers of neurosyphilis

8. CXCL13 is a highly sensitive and specific CSF (show CSF2 ELISA Kits) marker that helps to differentiate Lyme neuroborreliosis from other central nervous system disorders in children.

9. Study suggested that maternal rs355687 variant in CXCL13 gene was associated with decreased risk of HBV intrauterine infection compared to those with CC genotypes.

10. Elevations in serum MDC (show ADAM11 ELISA Kits) and BLC were independently associated with the significant risk of early stage lung adenocarcinoma, even in non-smokers and in stage IA patients.